Coliprotec F4/F18
porcine post-weaning diarrhoea vaccine (live)
Table of contents
Overview
This is a summary of the European public assessment report (EPAR) for Coliprotec F4/F18. It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use Coliprotec F4/F18.
For practical information about using Coliprotec F4/F18, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.
Authorisation details
Product details | |
---|---|
Name |
Coliprotec F4/F18
|
Agency product number |
EMEA/V/C/004225
|
Active substance |
Live non-pathogenic Escherichia coli O141:K94 (F18ac) and O8:K87 (F4ac)
|
International non-proprietary name (INN) or common name |
porcine post-weaning diarrhoea vaccine (live)
|
Species |
Pigs
|
Anatomical therapeutic chemical veterinary (ATCvet) codes |
QI09AE03
|
Publication details | |
---|---|
Marketing-authorisation holder |
Elanco GmbH
|
Revision |
5
|
Date of issue of marketing authorisation valid throughout the European Union |
09/01/2017
|
Contact address |
Heinz-Lohmann-Str. 4 |
Product information
11/11/2021 Coliprotec F4/F18 - EMEA/V/C/004225 - R/0009
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
-
Immunologicals for suidae
-
Live bacterial vaccines
Therapeutic indication
For active immunisation of pigs from 18 days of age against enterotoxigenic F4-positive and F18-positive Escherichia coli in order to reduce the incidence of moderate to severe post-weaning E. coli diarrhoea (PWD) in infected pigs and to reduce the faecal shedding of enterotoxigenic F4-positive and F18-positive E. coli from infected pigs.